BACKGROUND: Mohr-Tranebjaerg syndrome (MTS) is an X-linked, recessive, syndromic sensorineural hearing loss (HL) characterized by onset of deafness in childhood followed later in adult life by progressive neural degeneration affecting the brain and optic nerves. MTS is caused by mutations in the DDP/TIMM8A gene, which encodes for a 97 amino acid polypeptide; this polypeptide is a translocase of the inner mitochondrial membrane. OBJECTIVES: To describe the otologic presentation and temporal bone histopathology in four affected individuals with MTS. MATERIAL AND METHODS: All four subjects belonged to a large, multigenerational Norwegian family and were known to carry a frame shift mutation in the TIMM8A gene. Temporal bones were removed at autopsy and studied by light microscopy. Cytocochleograms were constructed for hair cells, stria vascularis, and cochlear neuronal cells. Vestibular neurons were also counted. RESULTS: All four subjects developed progressive HL in early childhood, becoming profoundly deaf by the age of 10 years. All four developed language, and at least one subject used amplification in early life. Audiometric evaluation in two subjects showed 80- to 100-dB HL by the age of 10 years. The subjects died between the ages of 49 and 67. The otopathology was strikingly similar in that all bones examined showed near-total loss of cochlear neuronal cells and severe loss of vestibular neurons. When compared with age-matched controls, there was 90% to 95% loss of cochlear neurons and 75% to 85% loss of vestibular neurons. CONCLUSIONS: We infer that the HL in MTS is likely to be the result of a postnatal and progressive degeneration of cochlear neurons and that MTS constitutes a true auditory neuropathy. Our findings have implications for clinical diagnosis of patients with MTS and management of the HL.
BACKGROUND:Mohr-Tranebjaerg syndrome (MTS) is an X-linked, recessive, syndromic sensorineural hearing loss (HL) characterized by onset of deafness in childhood followed later in adult life by progressive neural degeneration affecting the brain and optic nerves. MTS is caused by mutations in the DDP/TIMM8A gene, which encodes for a 97 amino acid polypeptide; this polypeptide is a translocase of the inner mitochondrial membrane. OBJECTIVES: To describe the otologic presentation and temporal bone histopathology in four affected individuals with MTS. MATERIAL AND METHODS: All four subjects belonged to a large, multigenerational Norwegian family and were known to carry a frame shift mutation in the TIMM8A gene. Temporal bones were removed at autopsy and studied by light microscopy. Cytocochleograms were constructed for hair cells, stria vascularis, and cochlear neuronal cells. Vestibular neurons were also counted. RESULTS: All four subjects developed progressive HL in early childhood, becoming profoundly deaf by the age of 10 years. All four developed language, and at least one subject used amplification in early life. Audiometric evaluation in two subjects showed 80- to 100-dB HL by the age of 10 years. The subjects died between the ages of 49 and 67. The otopathology was strikingly similar in that all bones examined showed near-total loss of cochlear neuronal cells and severe loss of vestibular neurons. When compared with age-matched controls, there was 90% to 95% loss of cochlear neurons and 75% to 85% loss of vestibular neurons. CONCLUSIONS: We infer that the HL in MTS is likely to be the result of a postnatal and progressive degeneration of cochlear neurons and that MTS constitutes a true auditory neuropathy. Our findings have implications for clinical diagnosis of patients with MTS and management of the HL.
Authors: Luis A Aguirre; Ignacio del Castillo; Alfons Macaya; Carme Medá; Manuela Villamar; Miguel A Moreno-Pelayo; Felipe Moreno Journal: Am J Med Genet A Date: 2006-02-15 Impact factor: 2.802
Authors: Emily Buss; Robert F Labadie; Carolyn J Brown; Aimee J Gross; John H Grose; Harold C Pillsbury Journal: Otol Neurotol Date: 2002-05 Impact factor: 2.311
Authors: L Tranebjaerg; C Schwartz; H Eriksen; S Andreasson; V Ponjavic; A Dahl; R E Stevenson; M May; F Arena; D Barker Journal: J Med Genet Date: 1995-04 Impact factor: 6.318
Authors: H Jin; M May; L Tranebjaerg; E Kendall; G Fontán; J Jackson; S H Subramony; F Arena; H Lubs; S Smith; R Stevenson; C Schwartz; D Vetrie Journal: Nat Genet Date: 1996-10 Impact factor: 38.330
Authors: Lucas M Viana; Jennifer T O'Malley; Barbara J Burgess; Dianne D Jones; Carlos A C P Oliveira; Felipe Santos; Saumil N Merchant; Leslie D Liberman; M Charles Liberman Journal: Hear Res Date: 2015-05-19 Impact factor: 3.208
Authors: Joseph P Roche; Benjamin Y Huang; Mauricio Castillo; Marc K Bassim; Oliver F Adunka; Craig A Buchman Journal: Otol Neurotol Date: 2010-07 Impact factor: 2.311
Authors: Esther Meyer; Michel Michaelides; Louise J Tee; Anthony G Robson; Fatimah Rahman; Shanaz Pasha; Linda M Luxon; Anthony T Moore; Eamonn R Maher Journal: Mol Vis Date: 2010-04-13 Impact factor: 2.367